Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows
Go back to Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows| (NASDAQ: GPCR) | Delayed: 46.84 -0.96 (2.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.80 | 52 Week High | $ | |||
| Open | $48.21 | 52 Week Low | $ | |||
| Day High | $48.25 | P/E | N/A | |||
| Day Low | $46.37 | EPS | $ | |||
| Volume | 55,069 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1154.19 -5.89 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.08 | 52 Week High | $88.16 | |||
| Open | $1170.00 | 52 Week Low | $67.88 | |||
| Day High | $1171.66 | P/E | 267.17 | |||
| Day Low | $1137.50 | EPS | $4.32 | |||
| Volume | 511,710 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.91 +0.14 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.77 | 52 Week High | $59.00 | |||
| Open | $47.99 | 52 Week Low | $32.80 | |||
| Day High | $48.00 | P/E | N/A | |||
| Day Low | $46.57 | EPS | $0.00 | |||
| Volume | 3,683,393 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 34.07 +0.57 (1.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.50 | 52 Week High | $5.17 | |||
| Open | $34.00 | 52 Week Low | $0.94 | |||
| Day High | $34.45 | P/E | N/A | |||
| Day Low | $33.68 | EPS | $0.00 | |||
| Volume | 341,377 | |||||

